What does this research mean for the field?

Type 2 diabetes comprises three distinct clinical phenotypes driven primarily by triglycerides and BMI rather than HbA1c, which exhibit significantly different complication burdens and require tailored treatment strategies. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.CHALLENGES_CONSENSUS.

What question did this study set out to answer?

To classify type 2 diabetes into distinct phenotypes based on metabolic profiles and complications.

June 7, 2026Diabetes

Metabolic-driven high-risk phenotype linked to ~294% higher complication odds vs age-driven moderate-risk phenotype despite younger age.

Q: What is the clinical evidence from this study?

Study design: Observational. Population: Type 2 Diabetes (n=217). Intervention: Metabolic-Driven High Risk phenotype (Phenotype 1) vs. Age-Driven Moderate Risk phenotype (Phenotype 2). Primary outcome: Multi-complication rate (bone disease, neuropathy, dyslipidemia, hepatic steatosis) (OR 3.94, 95% CI 1.89-8.21).

View Full Paper

Ask AI

Bookmark

Why the study?

Patients with similar HbA1c exhibit vastly different complication profiles, prompting the use of unsupervised machine learning to identify distinct type 2 diabetes phenotypes with differential complication burdens.

Does unsupervised machine learning identify distinct clinical phenotypes with differential complication burden in patients with Type 2 Diabetes?

Population

217 T2DM patients across multiple diabetes screening camps

Comparison

K-means clustering phenotypes based on clinical and metabolic markers

Design

Cross-sectional unsupervised machine learning study

Key result

The Metabolic-Driven High Risk phenotype had 3.9-fold higher complication odds than the Age-Driven Moderate Risk phenotype (OR 3.94; 95% CI 1.89-8.21) despite being 7 years younger.

Authors

SPSHUBHASHREE PATIL

Discussion

Member takes

Overview

Hypothesis-generating for metabolic phenotyping in T2DM; prospective validation needed before clinical adoption.

Key Points

To classify type 2 diabetes into distinct phenotypes based on metabolic profiles and complications.
K-means clustering applied to 217 T2DM patients with complete data.
Analysis included age, gender, BMI, HbA1c, lipid panel, diabetes duration, and metabolic markers.
Characterization of metabolic profiles and complication prevalence for each phenotype.
Three phenotypes identified: 1) Metabolic-Driven High Risk (32%): higher complications despite younger age; 2) Age-Driven Moderate Risk (44%): typical profile with moderate dyslipidemia; 3) Young Well-Controlled (24%): better control and fewer complications.
Phenotype 1 exhibited 3.9-fold higher complications compared to Phenotype 2 (OR 3.94, 95% CI 1.89-8.21).
High triglycerides (>200 mg/dL) and BMI (>30) were significant discriminators between phenotypes.

Study Design

Type

Observational (n=217)

Multicenter

Yes

Structured PICO

Does unsupervised machine learning identify distinct clinical phenotypes with differential complication burden in patients with Type 2 Diabetes?

Population

217 patients with type 2 diabetes from multiple screening camps, analyzed via unsupervised machine learning to identify distinct clinical phenotypes.

Exposure

Unsupervised machine learning (K-means clustering) using age, gender, BMI, HbA1c, lipid panel (total cholesterol, triglycerides, LDL, HDL, VLDL), diabetes duration, and metabolic markers.

Outcome

Identification of distinct phenotypes and their complication prevalence (bone disease, neuropathy, dyslipidemia, hepatic steatosis).

Main Result

Odds Ratio: 3.94 (95% CI 1.89–8.21)

Absolute Event Rate: 71% vs 48%

Unsupervised machine learning identified three distinct T2DM phenotypes driven primarily by triglycerides and BMI rather than HbA1c, revealing significantly different complication burdens that could guide precision treatment.

Cite This Study

SHUBHASHREE PATIL (2026) conducted an observational in Type 2 Diabetes (n=217). Metabolic-Driven High Risk phenotype (Phenotype 1) vs. Age-Driven Moderate Risk phenotype (Phenotype 2) was evaluated on Multi-complication rate (bone disease, neuropathy, dyslipidemia, hepatic steatosis) (OR 3.94, 95% CI 1.89-8.21). The Metabolic-Driven High Risk phenotype had 3.9-fold higher complication odds than the Age-Driven Moderate Risk phenotype (OR 3.94; 95% CI 1.89-8.21) despite being 7 years younger.

synapsesocial.com/papers/6a250c957def13d035e1ccc0 https://doi.org/10.2337/db26-2272-p

View Full Paper

Ask AI

Bookmark

June 7, 2026Diabetes

Metabolic-driven high-risk phenotype linked to ~294% higher complication odds vs age-driven moderate-risk phenotype despite younger age.

View Full Paper

Ask AI

Bookmark

Why the study?

Does unsupervised machine learning identify distinct clinical phenotypes with differential complication burden in patients with Type 2 Diabetes?

Population

217 T2DM patients across multiple diabetes screening camps

Comparison

K-means clustering phenotypes based on clinical and metabolic markers

Design

Cross-sectional unsupervised machine learning study

Key result

The Metabolic-Driven High Risk phenotype had 3.9-fold higher complication odds than the Age-Driven Moderate Risk phenotype (OR 3.94; 95% CI 1.89-8.21) despite being 7 years younger.

Authors

SPSHUBHASHREE PATIL

Discussion

Member takes

Overview

Hypothesis-generating for metabolic phenotyping in T2DM; prospective validation needed before clinical adoption.

Key Points

To classify type 2 diabetes into distinct phenotypes based on metabolic profiles and complications.
K-means clustering applied to 217 T2DM patients with complete data.
Analysis included age, gender, BMI, HbA1c, lipid panel, diabetes duration, and metabolic markers.
Characterization of metabolic profiles and complication prevalence for each phenotype.
Three phenotypes identified: 1) Metabolic-Driven High Risk (32%): higher complications despite younger age; 2) Age-Driven Moderate Risk (44%): typical profile with moderate dyslipidemia; 3) Young Well-Controlled (24%): better control and fewer complications.
Phenotype 1 exhibited 3.9-fold higher complications compared to Phenotype 2 (OR 3.94, 95% CI 1.89-8.21).
High triglycerides (>200 mg/dL) and BMI (>30) were significant discriminators between phenotypes.

Study Design

Type

Observational (n=217)

Multicenter

Yes

Structured PICO

Does unsupervised machine learning identify distinct clinical phenotypes with differential complication burden in patients with Type 2 Diabetes?

Population

217 patients with type 2 diabetes from multiple screening camps, analyzed via unsupervised machine learning to identify distinct clinical phenotypes.

Exposure

Unsupervised machine learning (K-means clustering) using age, gender, BMI, HbA1c, lipid panel (total cholesterol, triglycerides, LDL, HDL, VLDL), diabetes duration, and metabolic markers.

Outcome

Identification of distinct phenotypes and their complication prevalence (bone disease, neuropathy, dyslipidemia, hepatic steatosis).

Main Result

Odds Ratio: 3.94 (95% CI 1.89–8.21)

Absolute Event Rate: 71% vs 48%

Cite This Study

synapsesocial.com/papers/6a250c957def13d035e1ccc0 https://doi.org/10.2337/db26-2272-p

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark